|Articles|April 17, 2012

Supreme Court to Consider Sales Rep Overtime

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First

ByAndy Studna, Senior Editor

August 31st 2026

As integrated AI platforms take on the seam-bridging work of clinical trial operations, the field looks to precedent from aviation and medicine to chart a path toward a smaller, more accountable operational team. Credit: Stock.Adobe.com/Deemerwha studio.

Workforce Compression in AI-Driven Clinical Trial Operations

ByErvin Mazniku, MD, PhD(c)

August 31st 2026

ACT Brief: Site Cash Runway and Payment Infrastructure Priority, Biomarker Cut-Off Selection and Disparities, and Batch Failure Prevention Systems

ByAndy Studna, Senior Editor

August 31st 2026

© photon_photo - © photon_photo - stock.adobe.com

Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology

ByPeter Schüler, MD,Jack L. Martin, MD, FACC

August 28th 2026

How Urgent Is the Site Payment Problem, and Is the Industry Finally Taking It Seriously?

ByPatrick Mizer,Andy Studna, Senior Editor

August 28th 2026

Supreme Court to Consider Sales Rep Overtime

Related Content

Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First

Workforce Compression in AI-Driven Clinical Trial Operations

ACT Brief: Site Cash Runway and Payment Infrastructure Priority, Biomarker Cut-Off Selection and Disparities, and Batch Failure Prevention Systems

Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology

How Urgent Is the Site Payment Problem, and Is the Industry Finally Taking It Seriously?

Trending on Applied Clinical Trials Online

Workforce Compression in AI-Driven Clinical Trial Operations

Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology

AI Is Moving Faster Than Any Technology Before It

Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First

How Urgent Is the Site Payment Problem, and Is the Industry Finally Taking It Seriously?